Search Results

Display Settings
Results per page: 10
Sort By: Relevance
Filter
  • 1-10 of  6,749 results for ""Sitagliptin Phosphate""

Your Filters

Reset filters
Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request
Academic Journal

Solid-State Phase Transformation of Monohydrate and Anhydrous Form II of Sitagliptin Phosphate into a Novel Anhydrous Form IV - Solvent-Driven, Temperature-Induced and Stress Testings.

  • Authors : Chachorovska M; Research and Development, Alkaloid AD, Bul. Aleksandar Makedonski 12, 1000 Skopje, North Macedonia. Electronic address: .; Lefton JB

Subjects: Sitagliptin Phosphate* ; Ethanol*; Temperature

  • Source: Journal of pharmaceutical sciences [J Pharm Sci] 2024 Feb; Vol. 113 (2), pp. 396-406. Date of Electronic Publication: 2023 Nov 14.Publisher: Elsevier Country of Publication: United States NLM ID: 2985195R Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

Read More Add to Saved list
×
Academic Journal

Environmentally friendly protocol for the determination of sitagliptin phosphate in pharmaceutical preparations and biological fluids using l-tyrosine as a fluorescence probe.

  • Authors : Khan MN; Department of Chemistry, Allama Iqbal Open University, Islamabad, Pakistan.; Jan MN

Subjects: Sitagliptin Phosphate* ; Tyrosine*; Fluorescence

  • Source: Luminescence : the journal of biological and chemical luminescence [Luminescence] 2023 Oct; Vol. 38 (10), pp. 1803-1813. Date of Electronic Publication: 2023 Aug 21.Publisher: Wiley & Sons Country of Publication: England NLM ID: 100889025 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

Read More Add to Saved list
×
Academic Journal

Sitagliptin alleviates renal steatosis and endoplasmic reticulum stress in high fat diet-induced obese rats by targeting SREBP-1/CD36 signaling pathway.

  • Authors : Elseweidy MM; Biochemistry Department, Faculty of Pharmacy, Zagazig University, Zagazig, 44519, Egypt. Electronic address: .; Asker ME

Subjects: CD36 Antigens*/CD36 Antigens*/CD36 Antigens*/metabolism ; CD36 Antigens*/CD36 Antigens*/CD36 Antigens*/genetics ; Diet, High-Fat*/Diet, High-Fat*/Diet, High-Fat*/adverse effects

  • Source: European journal of pharmacology [Eur J Pharmacol] 2024 Aug 15; Vol. 977, pp. 176745. Date of Electronic Publication: 2024 Jun 14.Publisher: Elsevier Science Country of Publication: Netherlands NLM ID: 1254354 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

Read More Add to Saved list
×
Academic Journal

Exploration and detection of nitrosamine impurity nitroso-STG-19 in sitagliptin tablets and API as well as nitrites in excipients by LC-MS/MS methods.

  • Authors : Hao Y; National Engineering Research Center of Chiral Drugs, Lunan Pharmaceutical Group, Fei County, Linyi, Shandong, China. .; Fu J

Subjects: Tandem Mass Spectrometry*/Tandem Mass Spectrometry*/Tandem Mass Spectrometry*/methods ; Tablets* ; Nitrosamines*/Nitrosamines*/Nitrosamines*/analysis

  • Source: Analytical methods : advancing methods and applications [Anal Methods] 2024 Aug 01; Vol. 16 (30), pp. 5288-5295. Date of Electronic Publication: 2024 Aug 01.Publisher: RSC Pub Country of Publication: England NLM ID: 101519733 Publication Model: Electronic Cited Medium: Internet ISSN: 1759-9679

Record details

Read More Add to Saved list
×
Academic Journal

Dipeptidyl peptidase 4 inhibitor sitagliptin decreases myocardial fibrosis and modulates myocardial insulin signaling in a swine model of chronic myocardial ischemia.

  • Authors : Harris DD; Division of Cardiothoracic Surgery, Department of Surgery, Cardiovascular Research Center, Rhode Island Hospital, Alpert Medical School of Brown University, Providence, RI, United States of America.; Sabe SA

Subjects: Sitagliptin Phosphate*/Sitagliptin Phosphate*/Sitagliptin Phosphate*/pharmacology ; Sitagliptin Phosphate*/Sitagliptin Phosphate*/Sitagliptin Phosphate*/therapeutic use ; Fibrosis*

  • Source: PloS one [PLoS One] 2024 Jul 29; Vol. 19 (7), pp. e0307922. Date of Electronic Publication: 2024 Jul 29 (Print Publication: 2024).Publisher: Public Library of Science Country of Publication: United States NLM ID: 101285081 Publication Model: eCollection Cited Medium: Internet

Record details

Read Online Read More Add to Saved list
×
Academic Journal

Effect of sitagliptin therapy on IL-29 and its associated signaling molecules in patients with type 2 diabetes mellitus.

  • Authors : Nabiyi S; Department of Immunology, School of Medicine, Hamadan University of Medical Sciences, Hamadan, Iran.; Sajedi F

Subjects: Sitagliptin Phosphate*/Sitagliptin Phosphate*/Sitagliptin Phosphate*/therapeutic use ; Sitagliptin Phosphate*/Sitagliptin Phosphate*/Sitagliptin Phosphate*/pharmacology ; Diabetes Mellitus, Type 2*/Diabetes Mellitus, Type 2*/Diabetes Mellitus, Type 2*/drug therapy

  • Source: Human immunology [Hum Immunol] 2024 Jul; Vol. 85 (4), pp. 110833. Date of Electronic Publication: 2024 Jun 18.Publisher: Elsevier/North-Holland Country of Publication: United States NLM ID: 8010936 Publication Model: Print-Electronic Cited Medium: Internet

Record details

Read More Add to Saved list
×
Academic Journal

Individual dipeptidyl peptidase-4 inhibitors and acute kidney injury in patients with type 2 diabetes: A systematic review and network meta-analysis.

Subjects: Dipeptidyl-Peptidase IV Inhibitors*/Dipeptidyl-Peptidase IV Inhibitors*/Dipeptidyl-Peptidase IV Inhibitors*/adverse effects ; Acute Kidney Injury*/Acute Kidney Injury*/Acute Kidney Injury*/chemically induced ; Diabetes Mellitus, Type 2*/Diabetes Mellitus, Type 2*/Diabetes Mellitus, Type 2*/drug therapy

  • Source: Basic & clinical pharmacology & toxicology [Basic Clin Pharmacol Toxicol] 2024 Jul; Vol. 135 (1), pp. 71-80. Date of Electronic Publication: 2024 May 02.Publisher: Blackwell Country of Publication: England NLM ID: 101208422 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1742-7843

Record details

Read More Add to Saved list
×
Academic Journal

β-cell function and long-term glycemic control in patients newly diagnosed with type 2 diabetes with moderate hyperglycemia after a 6-month course of basal insulin therapy.

  • Authors : Kuo CS; Division of Endocrinology and Metabolism, Department of Medicine, Taipei Veterans General Hospital, Taipei, Taiwan; School of Medicine, College of Medicine, National Yang Ming Chiao Tung University, Taipei, Taiwan.

Subjects: Diabetes Mellitus, Type 2*/Diabetes Mellitus, Type 2*/Diabetes Mellitus, Type 2*/drug therapy ; Diabetes Mellitus, Type 2*/Diabetes Mellitus, Type 2*/Diabetes Mellitus, Type 2*/blood ; Hypoglycemic Agents*/Hypoglycemic Agents*/Hypoglycemic Agents*/therapeutic use

  • Source: Diabetes research and clinical practice [Diabetes Res Clin Pract] 2024 Sep; Vol. 215, pp. 111814. Date of Electronic Publication: 2024 Aug 08.Publisher: Elsevier Scientific Publishers Country of Publication: Ireland NLM ID: 8508335 Publication Model: Print-Electronic Cited Medium: Internet

Record details

Read More Add to Saved list
×
Academic Journal

Targeting SIRT1/AMPK/Nrf2/NF-кB by sitagliptin protects against oxidative stress-mediated ER stress and inflammation during ANIT-induced cholestatic liver injury.

  • Authors : Mosaoa RM; Department of Biochemistry, Faculty of Science, King Abdulaziz University, Jeddah 22254, Saudi Arabia; Experimental Biochemistry Unit, King Fahad Medical Research Center, King Abdulaziz University, Jeddah, Saudi Arabia

Subjects: Sirtuin 1*/Sirtuin 1*/Sirtuin 1*/metabolism ; Oxidative Stress*/Oxidative Stress*/Oxidative Stress*/drug effects ; NF-E2-Related Factor 2*/NF-E2-Related Factor 2*/NF-E2-Related Factor 2*/metabolism

  • Source: Toxicology [Toxicology] 2024 Sep; Vol. 507, pp. 153889. Date of Electronic Publication: 2024 Jul 17.Publisher: Elsevier Country of Publication: Ireland NLM ID: 0361055 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1879-3185

Record details

Read More Add to Saved list
×
Academic Journal

Sitagliptin synergizes 5-fluorouracil efficacy in colon cancer cells through MDR1-mediated flux impairment and down regulation of NFκB2 and p-AKT survival proteins.

  • Authors : Eisa A; Molecular Biology Department, Genetic Engineering and Biotechnology Institute, University of Sadat City, Sadat City, Egypt.; Hanafy SM

Subjects: Sitagliptin Phosphate*/Sitagliptin Phosphate*/Sitagliptin Phosphate*/pharmacology ; Fluorouracil*/Fluorouracil*/Fluorouracil*/pharmacology ; Colonic Neoplasms*/Colonic Neoplasms*/Colonic Neoplasms*/metabolism

  • Source: Journal of biochemical and molecular toxicology [J Biochem Mol Toxicol] 2024 Aug; Vol. 38 (8), pp. e23796.Publisher: Wiley Country of Publication: United States NLM ID: 9717231 Publication Model: Print Cited Medium: Internet ISSN: 1099-0461

Record details

Read More Add to Saved list
×
  • 1-10 of  6,749 results for ""Sitagliptin Phosphate""